Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial

@article{Swain2008AmenorrheaIP,
  title={Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial},
  author={Sandra M Swain and Stephanie R. Land and Marcie Wallace Ritter and J. P. Costantino and Reena S. Cecchini and Eleftherios P Mamounas and Norman Wolmark and Patricia A. Ganz},
  journal={Breast Cancer Research and Treatment},
  year={2008},
  volume={113},
  pages={315-320}
}
The NSABP B-30 trial addresses whether amenorrhea after adjuvant chemotherapy increases survival. Preliminary to the trial outcome analysis, we examined the incidence of amenorrhea and its relationship to symptoms and quality of life (QOL) in the standard-care arm of this adjuvant breast cancer trial. Premenopausal women treated on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm were included. Questionnaires assessing menstrual history, QOL, and symptoms were administered at… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 49 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Bulbrook RD, Taylor DJ (eds) Commentaries on Research in Breast Disease

  • Rose DP Effect of cytotoxic agents, antihormonal therapy on endocrine function. In
  • Alan R. Liss, New York 320 Breast Cancer Res…
  • 2009

Similar Papers

Loading similar papers…